- Home
- VTRS vs WES Comparison
VTRS vs WES Comparison
Compare VTRS & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTRS | WES |
|---|---|---|
| Founded | 1961 | 2007 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 17.3B |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | VTRS | WES |
|---|---|---|
| Price | $18.32 | $45.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 15 |
| Target Price | $19.90 | ★ $49.46 |
| AVG Volume (30 Days) | ★ 8.0M | 1.1M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | 2.67% | ★ 8.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $14,299,900,000.00 | $3,843,403,000.00 |
| Revenue This Year | $3.36 | $23.68 |
| Revenue Next Year | $2.40 | $3.77 |
| P/E Ratio | $361.60 | ★ $14.73 |
| Revenue Growth | N/A | ★ 6.61 |
| 52 Week Low | $9.92 | $36.90 |
| 52 Week High | $18.75 | $50.07 |
Technical Indicators
Market Signals| Indicator | VTRS | WES |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 49.19 |
| Support Level | $15.94 | $39.86 |
| Resistance Level | $18.41 | $46.42 |
| Average True Range (ATR) | 0.45 | 0.77 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 74.19 | 60.20 |
Price Performance
Historical ComparisonAbout VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
About WES Western Midstream Partners LP
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.